Skip to content

Dextromethorphan versus Emblica officinalis extract premedication on cough suppression during advanced bronchoscopy: a randomized, double blind, placebo controlled trial

Dextromethorphan versus Emblica officinalis extract premedication on cough suppression during advanced bronchoscopy: a randomized, double blind, placebo controlled trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200903005
Enrollment
120
Registered
2020-09-03
Start date
2020-08-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung mass Mediastinal lymphadenopathy Cancer Lung nodule Consolidation Advanced fiberoptic bronchoscope miniprobe EBUS premedication dextromethorphan cough suppression Indian Gooseberry extract Emblica officinalis extract

Interventions

Premedication with oral dextromethorphan and Emblica officinalis extract improve cough tolerance during advanced bronchoscopy,Premedication with oral dextromethorphan improve cough tolerance during ad
Placebo Comparator Drug,Placebo Comparator Drug,Placebo Comparator Drug,Placebo Comparator Drug
Placebo,Dextromethorphan,Emblica officinalis extract,Emblica officinalis extract and dextromethorphan

Sponsors

Division of Pulmonary Disease and Pulmonary Critical Care
Lead Sponsor
Ratchadaphiseksomphot Endowment Fund
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients undergoing advanced fiberoptic bronchoscope at King Chulalongkorn Memorial hospital

Exclusion criteria

Exclusion criteria: Recent myocardial infarction or unstable angina within 6 weeks. Arrhythmia Stridor/ advanced central airway obstruction Moderate to severe hypoxemia(PaO2 < 60 mmHg.)or pulse oximetry < 90% Dextromethorphan allergy Discontinue antiplatelet < 5 days. Pregnancy and breastfeeding On Monoamine oxidase inhibitor Poor control diabetic mellitus OSA patients Dextromethorphan allergy

Design outcomes

Primary

MeasureTime frame
Cough score during the procedure during the procedure count cough sound during the procedure

Secondary

MeasureTime frame
Dose of midazolam during bronchoscopy during the procedure milligram during bronchoscopy,Duration of procedure during the procedure minute,Dose of lidocaine during bronchoscopy during the procedure microgram during bronchoscopy,Complicationduring and post procedure during and post the procedure events,Sore throat after procedure post procedure Visual analogue scale,Lowest desaturation during the procedure percent saturation,The difficult in carrying out the bronchoscopic procedure by physician during the procedure Visual analogue scale

Countries

Thailand

Contacts

Public ContactWanvisa Boonfueang

Faculty of Medicine&#44; Chulalongkorn University

wavisa_boon@yahoo.com0858747020

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026